Debt issues start being a problem as well, luckily deferred maturity dates. EBITDA to debt at some 3.5 + times and equity v total debt also not strong.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025